Stock Screener App

無料 -

インストール

7.10

1.75% 0.08

Alpha Tau Medical Ltd (DRTS)

概要ニュース株価時系列ディスカッション予測

Alpha Tau Medical Ltd (DRTS) 最新ニュース

Alpha Tau Medical Shares Fall After Piper Sandler Downgrade - marketscreener.com

Piper Sandler cuts Alpha Tau Medical stock rating on valuation - Investing.com South Africa

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Piper Sandler Reiterates Neutral Rating for Alpha Tau Medical (NASDAQ:DRTS) - MarketBeat

DRTS Receives Downgrade from Piper Sandler with Neutral Rating | - GuruFocus

Piper Sandler cuts Alpha Tau Medical stock rating on valuation By Investing.com - Investing.com Canada

Alpha Tau Medical (DRTS) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

Is Alpha Tau Medical Ltd. Equity Warrant benefiting from interest rate changes2025 Key Lessons & Long-Term Growth Portfolio Plans - mfd.ru

DRTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Exploring a 6.89% Upside in Innovative Cancer Treatment Technology - DirectorsTalk Interviews

Alpha Tau Medical (DRTSW) to Release Earnings on Thursday - Defense World

DRTS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighWhat's Next? - MarketBeat

H.C. Wainwright raises Alpha Tau Medical price target on Japan approval - Investing.com Nigeria

Shorts Report: Will Alpha Tau Medical Ltd benefit from rate cutsJuly 2025 Rallies & Daily Momentum Trading Reports - baoquankhu1.vn

Alpha Tau price target raised to $12 from $9 at H.C. Wainwright - Yahoo Finance

Alpha Tau Lands First International Approval as Japan Grants Mar - GuruFocus

Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS) - TipRanks

H.C. Wainwright Maintained Buy on Alpha Tau Medical Ltd. (DRTS) Feb 2026 - Meyka

HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT - Business Wire

Alpha Tau Medical Says Its Head and Neck Cancer Medication Received Japanese Marketing Approval - marketscreener.com

Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy - TipRanks

Alpha Tau Medical receives Japanese marketing approval for Alpha Dart in head and neck cancer - marketscreener.com

Japan grants Shonin approval for Alpha Tau (DRTS) Alpha DaRT cancer therapy - Stock Titan

Alpha Tau Medical Receives Japanese Marketing Approval for - GlobeNewswire

Alpha Tau Medical (DRTSW) Stock Analysis Report | Financials & Insights - Benzinga España

CEO Change: Will MPLX benefit from seasonalityPortfolio Gains Summary & Consistent Growth Equity Picks - baoquankhu1.vn

Risk Off: What is FORLUs valuation compared to sectorPortfolio Value Summary & Risk Controlled Stock Alerts - baoquankhu1.vn

Retail Trends: Will Alpha Tau Medical Ltd Equity Warrant benefit from rising consumer demand2025 Price Momentum & Fast Gain Stock Tips - baoquankhu1.vn

Macro Review: Will Plumas Bancorp benefit from rising consumer demandJuly 2025 Outlook & Reliable Price Action Trade Plans - baoquankhu1.vn

Aug PreEarnings: Can Alpha Tau Medical Ltd sustain its profitabilityJuly 2025 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn

Lucid Diagnostics (NASDAQ:LUCD) & Alpha Tau Medical (NASDAQ:DRTS) Financial Survey - Defense World

Support Test: Should I invest in Alpha Tau Medical Ltd. before earningsPortfolio Performance Report & Fast Gain Stock Trading Tips - mfd.ru

Alpha Tau Medical (NASDAQ:DRTS) Upgraded at Zacks Research - Defense World

Alpha Tau Medical (NASDAQ:DRTSW) Trading Down 2.2% – Should You Sell? - Defense World

VIX Spike: Is Alpha Tau Medical Ltd Equity Warrant in a bullish channelInsider Buying & Accurate Buy Signal Alerts - baoquankhu1.vn

Is Alpha Tau Medical Ltd. Equity Warrant stock overvalued or fairly priced2025 Market Overview & Safe Capital Preservation Plans - mfd.ru

Is Alpha Tau Medical Ltd. Equity Warrant stock a good pick for beginners2025 Stock Rankings & Real-Time Market Sentiment Reports - mfd.ru

What hedge fund activity signals for Alpha Tau Medical Ltd. stock2025 Short Interest & Accurate Entry and Exit Point Alerts - mfd.ru

Big Picture: What is the Moat Score of Alpha Tau Medical Ltd.Trade Risk Report & Free Risk Controlled Daily Trade Plans - mfd.ru

Can Alpha Tau Medical Ltd. Equity Warrant reach all time highs this yearDip Buying & AI Powered Buy/Sell Recommendations - mfd.ru

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: Unveiling a 10.74% Potential Upside in the Biotech Arena - DirectorsTalk Interviews

Should you buy the dip on Alpha Tau Medical Ltd. Equity WarrantPortfolio Profit Report & Consistent Profit Alerts - mfd.ru

What’s next for Alpha Tau Medical Ltd. stockQuarterly Earnings Report & Consistent Income Trade Recommendations - mfd.ru

Alpha Tau Medical (NASDAQ:DRTS) Shares Down 6.6%Here's What Happened - MarketBeat

H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛

Energy Moves: How does Alpha Tau Medical Ltd compare to its peersOptions Play & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

Alpha Tau Medical unveils strong pancreatic cancer Alpha DaRT data ahead of ASCO GI 2026 - MSN

IPO Launch: Is Alpha Tau Medical Ltd stock showing strong momentumQuarterly Profit Review & Capital Protection Trading Alerts - baoquankhu1.vn

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Increase in Short Interest - Defense World

Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Rises By 111.0% - MarketBeat

DRTSWAlpha Tau Medical Ltd Latest Stock News & Market Updates - Stock Titan

Alpha Tau Issues Letter to Shareholders - marketscreener.com

Alpha Tau Highlights Five Concurrent U.S. Trials With Multiple Milestones Ahead; Shares Slip - Nasdaq

Alpha Tau Outlines Aggressive 2026 Clinical Schedule and Manufacturing Ramp for Alpha DaRT Cancer Therapy - TipRanks

Alpha Tau Issues Letter to Shareholders: Five Concurrent - GlobeNewswire

Alpha Tau Medical Ltd. (DRTS) Stock Analysis: A Biotech Pioneer with 8.55% Upside Potential - DirectorsTalk Interviews

Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead - ChartMill

Aug Patterns: Can Alpha Tau Medical Ltd be recession proofPortfolio Update Summary & Community Trade Idea Sharing - baoquankhu1.vn

New Strong Sell Stocks for January 27th - Yahoo Finance

Entry Recap: How does Alpha Tau Medical Ltd compare to its peers2025 Market Outlook & Verified High Yield Trade Plans - baoquankhu1.vn

RPRX

$45.58

4.02%

MRNA

$52.39

9.46%

ROIV

$29.46

0.27%

BNTX

$103.05

0.96%

INSM

$143.69

4.21%

ONC

$291.08

2.66%

Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く